Breast Cancer Core Needle Biopsy Market By Biopsy Type (Fine Needle Core Biopsy, Vacuum-Assisted Core Biopsy, Image-Guided Core Biopsy, Automated Core Biopsy), By Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy, CT-Guided Biopsy, Others), By Needle Type (Automated Core Biopsy Needles, Semi-Automated Core Biopsy Needles, Disposable Biopsy Needles, Reusable Biopsy Needles), By Application (Tumor Detection, Tumor Grading & Staging, Post-Treatment Assessment, Research & Clinical Studies, Others), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Specialty Clinics, Academic & Research Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & Forecast Parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Breast Cancer Core Needle Biopsy Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. How is the rising global prevalence of breast cancer boosting biopsy demand?

3.2.2. Why are minimally invasive biopsy methods preferred over surgical procedures today?

3.2.3. How do advancements in imaging-guided technologies improve diagnostic accuracy rates?

3.3. Key industry pitfalls & challenges

3.3.1. How do false negatives and sampling errors limit biopsy reliability overall?

3.3.2. Why does the high cost of advanced biopsy systems restrict wider adoption?

3.3.3. How does the shortage of skilled professionals affect diagnostic capacity worldwide?

3.4. Market Opportunities

3.4.1. How can medical tourism expand access to advanced biopsy diagnostics globally?

3.4.2. Why are disposable single-use biopsy needles gaining demand in diagnostics?

3.4.3. How can AI-driven imaging analysis reduce diagnostic errors and repeat procedures?

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Breast Cancer Core Needle Biopsy Market, Biopsy Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Biopsy Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Fine Needle Core Biopsy

4.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3. Vacuum-Assisted Core Biopsy

4.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.4. Image-Guided Core Biopsy

4.4.1. Market Size and Forecast, 2025-2035 (USD Million)

4.5. Automated Core Biopsy

4.5.1. Market Size and Forecast, 2025-2035 (USD Million)

5. Breast Cancer Core Needle Biopsy Market, Guidance Technique Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Guidance Technique, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Ultrasound-Guided Biopsy

5.2.1. Market Size and Forecast, 2025-2035 (USD Million)

5.3. Stereotactic-Guided Biopsy

5.3.1. Market Size and Forecast, 2025-2035 (USD Million)

5.4. MRI-Guided Biopsy

5.4.1. Market Size and Forecast, 2025-2035 (USD Million)

5.5. CT-Guided Biopsy

5.5.1. Market Size and Forecast, 2025-2035 (USD Million)

5.6. Others

5.6.1. Market Size and Forecast, 2025-2035 (USD Million)

6. Breast Cancer Core Needle Biopsy Market, Needle Type Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Needle Type, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Automated Core Biopsy Needles

6.2.1. Market Size and Forecast, 2025-2035 (USD Million)

6.3. Semi-Automated Core Biopsy Needles

6.3.1. Market Size and Forecast, 2025-2035 (USD Million)

6.4. Disposable Biopsy Needles

6.4.1. Market Size and Forecast, 2025-2035 (USD Million)

6.5. Reusable Biopsy Needles

6.5.1. Market Size and Forecast, 2025-2035 (USD Million)

7. Breast Cancer Core Needle Biopsy Market, Application Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Application, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Tumour Detection

7.2.1. Market Size and Forecast, 2025-2035 (USD Million)

7.3. Tumour Grading & Staging

7.3.1. Market Size and Forecast, 2025-2035 (USD Million)

7.4. Post-Treatment Assessment

7.4.1. Market Size and Forecast, 2025-2035 (USD Million)

7.5. Research & Clinical Studies

7.5.1. Market Size and Forecast, 2025-2035 (USD Million)

7.6. Other

7.6.1. Market Size and Forecast, 2025-2035 (USD Million)

8. Breast Cancer Core Needle Biopsy Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals

8.2.1. Market Size and Forecast, 2025-2035 (USD Million)

8.3. Diagnostic Centers

8.3.1. Market Size and Forecast, 2025-2035 (USD Million)

8.4. Ambulatory Surgical Centers

8.4.1. Market Size and Forecast, 2025-2035 (USD Million)

8.5. Specialty Clinics

8.5.1. Market Size and Forecast, 2025-2035 (USD Million)

8.6. Academic & Research Institutes

8.6.1. Market Size and Forecast, 2025-2035 (USD Million)

8.7. Others

8.7.1. Market Size and Forecast, 2025-2035 (USD Million)

9. Breast Cancer Core Needle Biopsy Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Million)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Million)

9.2.2. North America Market Revenue, By Biopsy Type, 2025-2035

9.2.3. North America Market Revenue, By Guidance Technique, 2025-2035

9.2.4. North America Market Revenue, By Needle Type, 2025-2035

9.2.5. North America Market Revenue, By Application, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Biopsy Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Guidance Technique, 2025-2035

9.2.7.3. U.S. Market Revenue, By Needle Type, 2025-2035

9.2.7.4. U.S. Market Revenue, By Application, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Biopsy Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Guidance Technique, 2025-2035

9.2.8.3. Canada Market Revenue, By Needle Type, 2025-2035

9.2.8.4. Canada Market Revenue, By Application, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Million)

9.3.2. Europe Market Revenue, By Biopsy Type, 2025-2035

9.3.3. Europe Market Revenue, By Guidance Technique, 2025-2035

9.3.4. Europe Market Revenue, By Needle Type, 2025-2035

9.3.5. Europe Market Revenue, By Application, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Biopsy Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Guidance Technique, 2025-2035

9.3.7.3. Germany Market Revenue, By Needle Type, 2025-2035

9.3.7.4. Germany Market Revenue, By Application, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Biopsy Type, 2025-2035

9.3.8.2. France Market Revenue, By Guidance Technique, 2025-2035

9.3.8.3. France Market Revenue, By Needle Type, 2025-2035

9.3.8.4. France Market Revenue, By Application, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Biopsy Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Guidance Technique, 2025-2035

9.3.9.3. U.K. Market Revenue, By Needle Type, 2025-2035

9.3.9.4. U.K. Market Revenue, By Application, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Biopsy Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Guidance Technique, 2025-2035

9.3.10.3. Italy Market Revenue, By Needle Type, 2025-2035

9.3.10.4. Italy Market Revenue, By Application, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Biopsy Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Guidance Technique, 2025-2035

9.3.11.3. Spain Market Revenue, By Needle Type, 2025-2035

9.3.11.4. Spain Market Revenue, By Application, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Biopsy Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Guidance Technique, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Needle Type, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Application, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Million)

9.4.2. Asia Pacific Market Revenue, By Biopsy Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Guidance Technique, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Needle Type, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Application, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Biopsy Type, 2025-2035

9.4.7.2. China Market Revenue, By Guidance Technique, 2025-2035

9.4.7.3. China Market Revenue, By Needle Type, 2025-2035

9.4.7.4. China Market Revenue, By Application, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Biopsy Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Guidance Technique, 2025-2035

9.4.8.3. Japan Market Revenue, By Needle Type, 2025-2035

9.4.8.4. Japan Market Revenue, By Application, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Biopsy Type, 2025-2035

9.4.9.2. India Market Revenue, By Guidance Technique, 2025-2035

9.4.9.3. India Market Revenue, By Needle Type, 2025-2035

9.4.9.4. India Market Revenue, By Application, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Biopsy Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Guidance Technique, 2025-2035

9.4.10.3. Australia Market Revenue, By Needle Type, 2025-2035

9.4.10.4. Australia Market Revenue, By Application, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Biopsy Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Guidance Technique, 2025-2035

9.4.11.3. South Korea Market Revenue, By Needle Type, 2025-2035

9.4.11.4. South Korea Market Revenue, By Application, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Biopsy Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Guidance Technique, 2025-2035

9.4.12.3. Singapore Market Revenue, By Needle Type, 2025-2035

9.4.12.4. Singapore Market Revenue, By Application, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Biopsy Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Guidance Technique, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Needle Type, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Million)

9.5.2. Latin America Market Revenue, By Biopsy Type, 2025-2035

9.5.3. Latin America Market Revenue, By Guidance Technique, 2025-2035

9.5.4. Latin America Market Revenue, By Needle Type, 2025-2035

9.5.5. Latin America Market Revenue, By Application, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Biopsy Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Guidance Technique, 2025-2035

9.5.7.3. Brazil Market Revenue, By Needle Type, 2025-2035

9.5.7.4. Brazil Market Revenue, By Application, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Biopsy Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Guidance Technique, 2025-2035

9.5.8.3. Argentina Market Revenue, By Needle Type, 2025-2035

9.5.8.4. Argentina Market Revenue, By Application, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Biopsy Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Guidance Technique, 2025-2035

9.5.9.3. Mexico Market Revenue, By Needle Type, 2025-2035

9.5.9.4. Mexico Market Revenue, By Application, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Biopsy Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Guidance Technique, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Needle Type, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Application, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Million)

9.6.2. MEA Market Revenue, By Biopsy Type, 2025-2035

9.6.3. MEA Market Revenue, By Guidance Technique, 2025-2035

9.6.4. MEA Market Revenue, By Needle Type, 2025-2035

9.6.5. MEA Market Revenue, By Application, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Biopsy Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Guidance Technique, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Needle Type, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Application, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Biopsy Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Guidance Technique, 2025-2035

9.6.8.3. South Africa Market Revenue, By Needle Type, 2025-2035

9.6.8.4. South Africa Market Revenue, By Application, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Biopsy Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Guidance Technique, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Needle Type, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Becton, Dickinson and Company (BD)

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Hologic, Inc.

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. Devicor Medical Products, Inc.

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Argon Medical Devices, Inc.

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Cook Medical

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Cardinal Health

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Medtronic plc

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Boston Scientific Corporation

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Olympus Corporation

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. FUJIFILM Holdings Corporation

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Leica Biosystems

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. INRAD Inc.

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. STERYLAB S.r.l.

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Merit Medical Systems, Inc.

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. C.R. Bard, Inc.

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis